Expression of MLEC in glioma - The Human Protein Atlas

GLIOBLASTOMA MULTIFORME (TCGA) - Interactive survival scatter plotⁱ

The Survival Scatter plot shows the clinical status (i.e. dead or alive) for all individuals in the patient cohort, based on the same data that underlies the corresponding Kaplan-Meier plots. Patients that are alive at last time for follow-up are shown in blue and patients who have died during the study are shown in red.

The x-axis shows the expression levels (FPKM) of the investigated gene in the tumor tissue at the time of diagnosis. The y-axis shows the follow-up time after diagnosis (years). Both axes are complimented with kernel density curves demonstrating the data density over the axes. The top density plot shows the expression levels (FPKM) distribution among dead (red) and alive patients (blue). The right density plot shows the data density of the survived years of dead patients with high and low expression levels respectively, stratified using the cutoff indicated by the vertical dashed line through the Survival Scatter plot. This cutoff is automatically defined based on the FPKM cutoff that minimizes the p-score. The cutoff can be changed by dragging the vertical line or by entering a cutoff value in the square labeled "Current cut-off".

Under the Survival Scatter plot the p-score landscape (black curve; left axis) is shown together with dead median separation (red curve; right axis). Dead median separation is the difference in median mRNA expression between patients who have died with high and low expression, respectively. It is calculated as follows: median FPKM expression of dead patients with high expression - median FPKM expression of dead patients with low expression. This is intended to aid the user in visually exploring custom cutoffs and the associated p-scores and dead median separation.

Individual patient data is displayed and can be filtered by clicking on one or more of the category buttons on the top of the page. Categories describing expression level and patient information include: high, low, alive, dead, female, male and tumor stages. The scale of the x-axis can be toggled between linear and log-scale by clicking on the "x log" button. Mouse-over function shows TCGA ID, patient information and mRNA expression (FPKM) for each patient.

& Survival analysisⁱ

MLEC is not prognostic in Glioblastoma Multiforme (TCGA)

Stage:

Survival analysis

Current cut offⁱ :

Best expression cut offⁱ : 60.69

Median expressionⁱ : N/A

Median follow up timeⁱ : N/A

P scoreⁱ N/A

3-year survival highⁱ N/A

3-year survival lowⁱ N/A

TCGA RNA samplesⁱ

Average TPM

46.0

Number of samples

141

Samples

Sample	Description	TPM
TCGA-06-0644-01A	0 years, male, black or african american, stage:'--, dead, 384 days	117.6
TCGA-06-0747-01A	0 years, male, white, stage:'--, dead, 82 days	95.7
TCGA-06-2561-01A	0 years, female, white, stage:'--, dead, 537 days	91.0
TCGA-06-1804-01A	0 years, female, white, stage:'--, dead, 414 days	91.0
TCGA-28-5218-01A	0 years, male, white, stage:'--, dead, 157 days	82.0
TCGA-06-2565-01A	0 years, male, asian, stage:'--, dead, 506 days	81.2
TCGA-41-4097-01A	0 years, female, white, stage:'--, dead, 6 days	80.4
TCGA-12-3653-01A	0 years, female, white, stage:'--, dead, 442 days	80.2
TCGA-28-5209-01A	0 years, female, white, stage:'--, alive, 442 days	77.5
TCGA-14-0787-01A	0 years, male, asian, stage:'--, dead, 68 days	73.5
TCGA-15-0742-01A	0 years, male, white, stage:'--, dead, 419 days	73.3
TCGA-76-4929-01A	0 years, female, white, stage:'--, dead, 111 days	72.9
TCGA-06-2562-01A	0 years, male, white, stage:'--, dead, 382 days	72.6
TCGA-06-2564-01A	0 years, male, white, stage:'--, alive, 181 days	71.9
TCGA-27-1830-01A	0 years, male, white, stage:'--, dead, 154 days	71.4
TCGA-06-5408-01A	0 years, female, white, stage:'--, dead, 357 days	70.2
TCGA-28-5215-01A	0 years, female, white, stage:'--, dead, 335 days	68.3
TCGA-28-5204-01A	0 years, male, white, stage:'--, dead, 454 days	68.2
TCGA-06-0211-01A	0 years, male, white, stage:'--, dead, 360 days	67.6
TCGA-28-5208-01A	0 years, male, white, stage:'--, dead, 544 days	65.8
TCGA-76-4925-01A	0 years, male, white, stage:'--, dead, 146 days	63.8
TCGA-27-1834-01A	0 years, male, white, stage:'--, dead, 1233 days	63.0
TCGA-14-1034-01A	0 years, female, stage:'--, dead, 485 days	63.0
TCGA-06-0187-01A	0 years, male, white, stage:'--, dead, 828 days	62.8
TCGA-28-5207-01A	0 years, male, white, stage:'--, dead, 343 days	62.7
TCGA-19-2619-01A	0 years, female, black or african american, stage:'--, alive, 294 days	62.6
TCGA-76-4931-01A	0 years, female, white, stage:'--, dead, 279 days	62.5
TCGA-27-2523-01A	0 years, male, white, stage:'--, dead, 489 days	62.3
TCGA-26-5139-01A	0 years, female, white, stage:'--, alive, 48 days	61.6
TCGA-32-1970-01A	0 years, male, white, stage:'--, dead, 468 days	61.2
TCGA-14-0789-01A	0 years, male, white, stage:'--, dead, 342 days	61.1
TCGA-27-1837-01A	0 years, male, white, stage:'--, dead, 427 days	60.7
TCGA-06-0878-01A	0 years, male, white, stage:'--, alive, 218 days	60.6
TCGA-06-0125-01A	0 years, female, white, stage:'--, dead, 1448 days	60.4
TCGA-02-0047-01A	0 years, male, white, stage:'--, dead, 448 days	60.2
TCGA-06-5858-01A	0 years, female, white, stage:'--, alive, 187 days	59.0
TCGA-32-2638-01A	0 years, male, white, stage:'--, dead, 766 days	57.4
TCGA-76-4927-01A	0 years, male, white, stage:'--, dead, 535 days	56.7
TCGA-06-5412-01A	0 years, female, white, stage:'--, dead, 138 days	56.3
TCGA-12-5299-01A	0 years, female, white, stage:'--, dead, 98 days	55.7
TCGA-32-2634-01A	0 years, male, white, stage:'--, alive, 693 days	55.1
TCGA-06-0130-01A	0 years, male, white, stage:'--, dead, 394 days	54.8
TCGA-28-1753-01A	0 years, male, white, stage:'--, alive, 37 days	54.8
TCGA-15-1444-01A	0 years, male, white, stage:'--, dead, 1537 days	54.3
TCGA-27-2519-01A	0 years, male, white, stage:'--, dead, 550 days	54.3
TCGA-06-2563-01A	0 years, female, white, stage:'--, alive, 932 days	54.3
TCGA-19-5960-01A	0 years, male, white, stage:'--, dead, 455 days	53.8
TCGA-28-2509-01A	0 years, female, white, stage:'--, alive, 145 days	53.6
TCGA-06-5414-01A	0 years, male, white, stage:'--, alive, 273 days	53.1
TCGA-32-2616-01A	0 years, female, white, stage:'--, dead, 224 days	53.1
TCGA-06-2567-01A	0 years, male, white, stage:'--, dead, 133 days	51.4
TCGA-27-2528-01A	0 years, male, white, stage:'--, dead, 480 days	51.0
TCGA-06-0882-01A	0 years, male, white, stage:'--, dead, 632 days	50.3
TCGA-02-2485-01A	0 years, male, black or african american, stage:'--, alive, 470 days	50.1
TCGA-06-0158-01A	0 years, male, white, stage:'--, dead, 329 days	48.9
TCGA-06-5413-01A	0 years, male, white, stage:'--, alive, 268 days	48.6
TCGA-28-2514-01A	0 years, male, asian, stage:'--, alive, 160 days	48.5
TCGA-06-2557-01A	0 years, male, black or african american, stage:'--, dead, 33 days	48.3
TCGA-27-1832-01A	0 years, female, white, stage:'--, dead, 300 days	48.2
TCGA-19-1390-01A	0 years, female, white, stage:'--, dead, 772 days	48.1
TCGA-06-0210-01A	0 years, female, white, stage:'--, dead, 225 days	48.0
TCGA-06-0646-01A	0 years, male, white, stage:'--, dead, 175 days	47.7
TCGA-06-5859-01A	0 years, male, white, stage:'--, alive, 139 days	47.3
TCGA-12-0821-01A	0 years, male, white, stage:'--, dead, 323 days	46.2
TCGA-27-1835-01A	0 years, female, white, stage:'--, dead, 648 days	46.1
TCGA-19-2620-01A	0 years, male, white, stage:'--, dead, 148 days	46.0
TCGA-06-2558-01A	0 years, female, white, stage:'--, dead, 380 days	45.9
TCGA-14-1825-01A	0 years, male, white, stage:'--, dead, 232 days	45.8
TCGA-32-2632-01A	0 years, male, white, stage:'--, dead, 269 days	45.7
TCGA-06-0129-01A	0 years, male, asian, stage:'--, dead, 1024 days	45.6
TCGA-28-2513-01A	0 years, female, white, stage:'--, alive, 222 days	45.4
TCGA-32-2615-01A	0 years, male, white, stage:'--, dead, 485 days	44.9
TCGA-19-2629-01A	0 years, male, white, stage:'--, dead, 737 days	43.2
TCGA-26-5132-01A	0 years, male, white, stage:'--, alive, 286 days	42.8
TCGA-76-4932-01A	0 years, female, white, stage:'--, dead, 1458 days	41.5
TCGA-26-1442-01A	0 years, male, white, stage:'--, alive, 953 days	41.5
TCGA-27-2521-01A	0 years, male, white, stage:'--, dead, 510 days	41.5
TCGA-06-2559-01A	0 years, male, white, stage:'--, dead, 150 days	41.3
TCGA-26-5133-01A	0 years, male, white, stage:'--, alive, 452 days	40.8
TCGA-12-0619-01A	0 years, male, white, stage:'--, dead, 1062 days	39.9
TCGA-41-2572-01A	0 years, male, white, stage:'--, dead, 406 days	39.7
TCGA-06-0174-01A	0 years, male, white, stage:'--, dead, 98 days	39.4
TCGA-06-2569-01A	0 years, female, black or african american, stage:'--, alive, 13 days	39.4
TCGA-06-5410-01A	0 years, female, white, stage:'--, dead, 108 days	39.2
TCGA-12-3652-01A	0 years, male, white, stage:'--, dead, 1062 days	39.2
TCGA-28-5216-01A	0 years, male, white, stage:'--, alive, 415 days	38.8
TCGA-06-5416-01A	0 years, female, white, stage:'--, alive, 204 days	38.3
TCGA-32-1980-01A	0 years, male, white, stage:'--, dead, 36 days	37.9
TCGA-06-0168-01A	0 years, female, white, stage:'--, dead, 598 days	37.9
TCGA-06-0157-01A	0 years, female, white, stage:'--, dead, 97 days	37.7
TCGA-14-2554-01A	0 years, female, white, stage:'--, dead, 532 days	37.7
TCGA-08-0386-01A	0 years, male, white, stage:'--, dead, 548 days	37.4
TCGA-06-0190-01A	0 years, male, white, stage:'--, dead, 317 days	37.1
TCGA-26-5135-01A	0 years, female, white, stage:'--, dead, 270 days	36.6
TCGA-19-4065-01A	0 years, male, white, stage:'--, alive, 214 days	36.5
TCGA-41-3915-01A	0 years, male, white, stage:'--, dead, 360 days	35.8
TCGA-28-5220-01A	0 years, male, white, stage:'--, dead, 388 days	35.6
TCGA-06-5417-01A	0 years, female, white, stage:'--, alive, 155 days	35.3
TCGA-06-5856-01A	0 years, male, white, stage:'--, dead, 114 days	35.3
TCGA-06-5418-01A	0 years, female, white, stage:'--, dead, 83 days	35.1
TCGA-06-0645-01A	0 years, female, white, stage:'--, dead, 175 days	35.0
TCGA-06-0156-01A	0 years, male, white, stage:'--, dead, 178 days	35.0
TCGA-14-0871-01A	0 years, female, white, stage:'--, dead, 880 days	34.4
TCGA-06-2570-01A	0 years, female, white, stage:'--, alive, 958 days	34.4
TCGA-06-0750-01A	0 years, male, white, stage:'--, dead, 28 days	34.1
TCGA-41-5651-01A	0 years, female, black or african american, stage:'--, dead, 460 days	34.0
TCGA-02-2483-01A	0 years, male, asian, stage:'--, alive, 466 days	33.9
TCGA-06-0745-01A	0 years, male, white, stage:'--, dead, 239 days	33.8
TCGA-06-0743-01A	0 years, male, white, stage:'--, dead, 803 days	32.2
TCGA-32-5222-01A	0 years, male, white, stage:'--, dead, 585 days	31.7
TCGA-06-0686-01A	0 years, male, white, stage:'--, dead, 432 days	31.7
TCGA-19-2624-01A	0 years, male, white, stage:'--, dead, 5 days	31.2
TCGA-27-2524-01A	0 years, male, white, stage:'--, dead, 231 days	30.0
TCGA-06-0141-01A	0 years, male, white, stage:'--, dead, 313 days	29.9
TCGA-41-2571-01A	0 years, male, white, stage:'--, dead, 26 days	29.4
TCGA-32-4213-01A	0 years, female, white, stage:'--, alive, 604 days	29.3
TCGA-12-0618-01A	0 years, male, white, stage:'--, dead, 395 days	28.1
TCGA-02-2486-01A	0 years, male, white, stage:'--, dead, 618 days	28.1
TCGA-12-3650-01A	0 years, male, white, stage:'--, dead, 333 days	27.9
TCGA-32-1982-01A	0 years, female, white, stage:'--, dead, 142 days	27.7
TCGA-06-0132-01A	0 years, male, white, stage:'--, dead, 771 days	26.6
TCGA-06-0744-01A	0 years, male, white, stage:'--, dead, 1426 days	26.4
TCGA-06-5411-01A	0 years, male, white, stage:'--, dead, 254 days	26.0
TCGA-27-2526-01A	0 years, female, white, stage:'--, dead, 87 days	25.5
TCGA-16-0846-01A	0 years, male, white, stage:'--, dead, 119 days	25.2
TCGA-19-2625-01A	0 years, female, white, stage:'--, dead, 124 days	23.9
TCGA-12-5295-01A	0 years, female, white, stage:'--, dead, 454 days	23.3
TCGA-12-0616-01A	0 years, female, white, stage:'--, dead, 448 days	22.6
TCGA-14-1823-01A	0 years, female, white, stage:'--, dead, 543 days	22.5
TCGA-02-0055-01A	0 years, female, white, stage:'--, dead, 76 days	21.9
TCGA-06-0139-01A	0 years, male, white, stage:'--, dead, 362 days	20.8
TCGA-06-0184-01A	0 years, male, white, stage:'--, dead, 2126 days	19.9
TCGA-06-0238-01A	0 years, male, white, stage:'--, dead, 405 days	17.5
TCGA-14-0817-01A	0 years, female, white, stage:'--, dead, 164 days	16.8
TCGA-26-5134-01A	0 years, male, white, stage:'--, alive, 167 days	16.5
TCGA-06-0749-01A	0 years, male, black or african american, stage:'--, dead, 82 days	16.1
TCGA-06-0138-01A	0 years, male, white, stage:'--, dead, 737 days	14.3
TCGA-27-1831-01A	0 years, male, white, stage:'--, dead, 505 days	11.7
TCGA-06-0219-01A	0 years, male, white, stage:'--, dead, 22 days	8.9
TCGA-14-1829-01A	0 years, male, black or african american, stage:'--, alive, 218 days	8.2
TCGA-06-0178-01A	0 years, male, white, stage:'--, dead, 2681 days	6.0
Show allShow less

GLIOBLASTOMA MULTIFORME (VALIDATION) - Interactive survival scatter plotⁱ

& Survival analysisⁱ

MLEC is not prognostic in Glioblastoma Multiforme (validation)

Stage:

Survival analysis

Current cut offⁱ :

Best expression cut offⁱ : 39.12

Median expressionⁱ : N/A

Median follow up timeⁱ : N/A

P scoreⁱ N/A

3-year survival highⁱ N/A

3-year survival lowⁱ N/A

TCGA RNA samplesⁱ

Average TPM

46.8

Number of samples

Samples

Sample	Description	TPM
AK205	N, NA, stage:NA, dead, 120 days	83.2
AK153	N, NA, stage:NA, dead, 240 days	76.5
AK195	N, NA, stage:NA, dead, 390 days	71.1
AK178	N, NA, stage:NA, dead, 240 days	71.1
AK088	N, NA, stage:NA, dead, 360 days	70.4
AK099	N, NA, stage:NA, dead, 420 days	69.5
AK100	N, NA, stage:NA, alive, 960 days	66.5
AK227	N, NA, stage:NA, alive, 300 days	65.3
AK035	N, NA, stage:NA, dead, 210 days	64.4
AK185	N, NA, stage:NA, alive, 330 days	64.0
AK030	N, NA, stage:NA, dead, 120 days	62.4
AK043	N, NA, stage:NA, alive, 660 days	59.2
AK071	N, NA, stage:NA, dead, 540 days	57.9
AK139	N, NA, stage:NA, dead, 270 days	55.8
AK156	N, NA, stage:NA, dead, 330 days	55.2
AK051	N, NA, stage:NA, dead, 360 days	53.9
AK188	N, NA, stage:NA, alive, 420 days	53.2
AK226	N, NA, stage:NA, dead, 360 days	50.3
AK218	N, NA, stage:NA, dead, 180 days	49.6
AK117	N, NA, stage:NA, dead, 210 days	49.2
AK089	N, NA, stage:NA, dead, 330 days	49.0
AK098	N, NA, stage:NA, dead, 660 days	48.4
AK123	N, NA, stage:NA, dead, 180 days	48.3
AK216	N, NA, stage:NA, dead, 360 days	47.9
AK149	N, NA, stage:NA, dead, 420 days	47.2
AK081	N, NA, stage:NA, dead, 180 days	47.1
AK236	N, NA, stage:NA, dead, 360 days	46.7
AK076	N, NA, stage:NA, alive, 660 days	46.5
AK005	N, NA, stage:NA, dead, 240 days	46.3
AK091	N, NA, stage:NA, dead, 210 days	45.3
AK074	N, NA, stage:NA, alive, 300 days	43.9
AK133	N, NA, stage:NA, dead, 360 days	43.0
AK049	N, NA, stage:NA, dead, 180 days	42.7
AK006	N, NA, stage:NA, dead, 360 days	40.6
AK124	N, NA, stage:NA, alive, 1920 days	40.0
AK158	N, NA, stage:NA, dead, 360 days	39.3
AK072	N, NA, stage:NA, dead, 150 days	39.2
AK066	N, NA, stage:NA, alive, 960 days	39.0
AK103	N, NA, stage:NA, alive, 1320 days	38.7
AK003	N, NA, stage:NA, dead, 600 days	38.2
AK085	N, NA, stage:NA, alive, 660 days	37.8
AK053	N, NA, stage:NA, dead, 300 days	37.8
AK002	N, NA, stage:NA, dead, 570 days	36.8
AK167	N, NA, stage:NA, dead, 180 days	36.4
AK134	N, NA, stage:NA, dead, 360 days	36.0
AK231	N, NA, stage:NA, dead, 240 days	35.6
AK173	N, NA, stage:NA, dead, 180 days	35.4
AK055	N, NA, stage:NA, dead, 240 days	33.7
AK068	N, NA, stage:NA, alive, 360 days	33.6
AK165	N, NA, stage:NA, alive, 360 days	31.6
AK079	N, NA, stage:NA, dead, 210 days	31.6
AK015	N, NA, stage:NA, alive, 720 days	31.3
AK183	N, NA, stage:NA, alive, 360 days	31.2
AK213	N, NA, stage:NA, alive, 2010 days	31.1
AK041	N, NA, stage:NA, alive, 810 days	31.1
AK142	N, NA, stage:NA, alive, 90 days	30.0
AK199	N, NA, stage:NA, alive, 1860 days	28.6
AK102	N, NA, stage:NA, alive, 1740 days	24.2
Show allShow less

GLIOBLASTOMA MULTIFORME - Protein relative expression (CPTAC)

Number of samples

110

Samples

Sample ID	Sample type	nRPX
CPT0168080003	Tumor	1.1
CPT0162100003	Tumor	0.9
CPT0123530003	Tumor	0.9
CPT0205780003	Tumor	0.7
CPT0206780003	Tumor	0.7
CPT0206670004	Tumor	0.7
CPT0216920008	Tumor	0.6
CPT0078580003	Tumor	0.6
CPT0087950003	Tumor	0.6
CPT0217000004	Tumor	0.5
CPT0189750004	Tumor	0.5
CPT0093590003	Tumor	0.5
CPT0221180003	Tumor	0.5
CPT0093360003	Tumor	0.5
CPT0207090003	Tumor	0.5
CPT0206230003	Tumor	0.5
CPT0182500003	Tumor	0.4
CPT0205570003	Tumor	0.4
CPT0093550003	Tumor	0.4
CPT0087680003	Tumor	0.3
CPT0218690004	Tumor	0.3
CPT0206560003	Tumor	0.3
CPT0219080004	Tumor	0.3
CPT0093510003	Tumor	0.3
CPT0186100003	Tumor	0.3
CPT0093450003	Tumor	0.3
CPT0125570003	Tumor	0.3
CPT0064890003	Tumor	0.3
CPT0209440003	Tumor	0.2
CPT0189570004	Tumor	0.2
CPT0171580008	Tumor	0.2
CPT0189460003	Tumor	0.2
CPT0168480003	Tumor	0.2
CPT0205450004	Tumor	0.2
CPT0089150003	Tumor	0.2
CPT0167530003	Tumor	0.2
CPT0167970003	Tumor	0.2
CPT0189850004	Tumor	0.1
CPT0190360004	Tumor	0.1
CPT0127480003	Tumor	0.1
CPT0079790003	Tumor	0.1
CPT0224600003	Tumor	0.1
CPT0167640003	Tumor	0.1
CPT0217060003	Tumor	0.1
CPT0206000004	Tumor	0.1
CPT0002410011	Tumor	0.1
CPT0218830004	Tumor	0.1
CPT0168830003	Tumor	0.1
CPT0218330004	Tumor	0.1
CPT0217710008	Tumor	0.1
CPT0125220003	Tumor	0.1
CPT0205670004	Tumor	0.0
CPT0205890003	Tumor	0.0
CPT0206880003	Tumor	0.0
CPT0224540004	Tumor	0.0
CPT0167750004	Tumor	0.0
CPT0217430008	Tumor	-0.1
CPT0206110003	Tumor	-0.1
CPT0224390004	Tumor	-0.1
CPT0168720003	Tumor	-0.1
CPT0162140003	Tumor	-0.1
CPT0162020003	Tumor	-0.1
CPT0087730003	Tumor	-0.1
CPT0218890004	Tumor	-0.1
CPT0189650004	Tumor	-0.1
CPT0168590003	Tumor	-0.1
CPT0206450003	Tumor	-0.1
CPT0199770003	Tumor	-0.1
CPT0071100003	Tumor	-0.1
CPT0182580003	Tumor	-0.1
CPT0190240004	Tumor	-0.1
CPT0218670003	Tumor	-0.2
CPT0092440003	Tumor	-0.2
CPT0087570003	Tumor	-0.2
CPT0167860004	Tumor	-0.2
CPT0175060003	Tumor	-0.2
CPT0064650003	Tumor	-0.2
CPT0217880003	Tumor	-0.2
CPT0189250003	Tumor	-0.2
CPT0217190003	Tumor	-0.2
CPT0201710003	Tumor	-0.2
CPT0207030003	Tumor	-0.2
CPT0224330003	Tumor	-0.2
CPT0125510003	Tumor	-0.3
CPT0104330003	Tumor	-0.3
CPT0168380003	Tumor	-0.3
CPT0182550003	Tumor	-0.3
CPT0127420003	Tumor	-0.3
CPT0168270003	Tumor	-0.3
CPT0161730003	Tumor	-0.3
CPT0218960004	Tumor	-0.4
CPT0217100003	Tumor	-0.4
CPT0104220003	Tumor	-0.4
CPT0196850003	Tumor	-0.4
CPT0225760003	Tumor	-0.4
CPT0225730003	Tumor	-0.4
CPT0206330003	Tumor	-0.5
CPT0204390003	Normal	-0.5
CPT0204340003	Normal	-0.5
CPT0208980003	Tumor	-0.5
CPT0204330003	Normal	-0.5
CPT0204360003	Normal	-0.6
CPT0204420003	Normal	-0.6
CPT0218770003	Tumor	-0.6
CPT0204410003	Normal	-0.6
CPT0204400003	Normal	-0.6
CPT0228220003	Tumor	-0.7
CPT0204370003	Normal	-0.7
CPT0204380003	Normal	-0.9
CPT0204350003	Normal	-1.1
Show allShow less

GLIOMA - Protein expressionⁱ

Pending cancer tissue analysis